Fear of black market means no RU-486 for Canada until US approves drug

B Sibbald, Sibbald B
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 1999 · vol. 160(12) , pp. 1753–4 · PMID:10410644 · PMC1230421
Other OA: closed
📄 Open PDF View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-12 ⓘ

This article discusses the eight-year delay in approving RU-486 for Canada due to fears of black market availability, noting that the situation has not slowed debate about the product.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Mifepristone, the "abortion pill" that is better known as RU-486, is no closer to arriving in Canada than it was 8 years ago. But that fact hasn't slowed debate about the product.

My notes (saved in your browser only)

MeSH descriptors

Abortifacient Agents, Steroidal Contraceptives, Oral, Synthetic Drug and Narcotic Control Drug Approval Mifepristone Canada Female Humans Pregnancy United States

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T20:58:57.924351+00:00